Abstract:Jiayi Li, 1 Gang Huang, 1 Juexin Wang, 1 Sui Wang, 1 Yanbo Yu 1, 2 1 Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, People's Republic of China; 2 Shandong Provincial Clinical Research Center for Digestive Disease, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China Correspondence: Yanbo Yu, Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, 250012, People's Republic of China, Tel +86-531-82166090, Email The redox balance in the intestine plays an important role in maintaining intestinal homeostasis, and it is closely related to the intestinal mucosal barrier, intestinal inflammation, and the gut microbiota. Current research on the treatment of ulcerative colitis has focused on immune disorders, excessive inflammation, and oxidative stress. However, an imbalance in intestinal redox reaction plays a particularly critical role. Hydrogen is produced by some anaerobic bacteria via hydrogenases in the intestine. Increasing evidence suggests that hydrogen, as an inert gas, is crucial for immunity, inflammation, and oxidative stress and plays a protective role in ulcerative colitis. Hydrogen maintains the redox state balance in the intestine in ulcerative colitis and reduces damage to intestinal epithelial cells by exerting its selective antioxidant ability. Hydrogen also regulates the intestinal flora, reduces the harmful effects of bacteria on the intestinal epithelial barrier, promotes the restoration of normal anaerobic bacteria in the intestines, and ultimately improves the integrity of the intestinal epithelial barrier. The present review focuses on the therapeutic mechanisms of hydrogen-targeting ulcerative colitis. Plain Language Summary: The balance of oxidation-reduction is crucial for maintaining the overall health of the intestines. However, disruption of this equilibrium leads to the development of various diseases, such as ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inflammation and ulcers in the lining of the colon and rectum. Abnormal oxidative stress in ulcerative colitis leads to the excessive activation of immune cells, heightened inflammation, and imbalance of gut microbiota, which accelerates the development of this disease. Hydrogen gas is a reducing gas that is produced by bacteria in the intestine or administered exogenously. It has an important selective antioxidant role and alleviates ulcerative colitis without interfering with normal physiological processes. The present article summarizes the direct and indirect effects of hydrogen gas on ulcerative colitis by analyzing the relevant literature, which indicates that hydrogen gas is a potential molecular drug for the treatment of ulcerative colitis. Keywords: inflammatory bowel disease, ulcerative colitis, oxidative stress, hydrogen, molecular medicine Graphical Ulcerative colitis (UC) is a complex, immune-mediated chronic inflammatory disease that primarily affects the rectum and colon. It is associated with various factors such as inflammation, oxidative stress, and disorders of the microflora. 1–3 Current treatment options for UC include medications, such as 5-aminosalicylic acid, corticosteroids, and biological agents such as infliximab. However, these drugs have side effects, and some patients may not respond well to these drugs. 4,5 The overall control of this disease using traditional treatments is unsatisfactory, which supports an increasing need to identify new drug treatment targets. 3,6,7 Molecular hydrogen is a recently discovered medical gas that has shown promising results in various clinical studies. It has the unique ability to penetrate cell membranes, spread to the cytoplasm, and target specific organelles. One of its key properties is its ability to selectively reduce cytotoxic oxygen radicals, such as hydroxyl radicals (·OH) and peroxynitrite (ONOO-), without affecting physiological reactive oxygen species (ROS) or reactive nitrogen species (RNS), which are involved in normal cell signaling. 8–13 This selective targeting makes hydrogen a safe and effective therapeutic option. Clinical experiments demonstrated the safety of hydrogen gas and showed its benefits in different medical fields, 14–16 including sports medicine, 17,18 cognitive impairment, 19 stroke, 20 cancer, 21 metabolic syndrome, 22 and in patients with COVID-19. 23,24 Animal models of ulcerative colitis also showed therapeutic effects of hydrogen, including anti-inflammation, anti-oxidative stress, regulation of endoplasmic reticulum stress, and regulation of the gut mi -Abstract Truncated-

Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal epithelial barrier

Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier

Zeolite-containing Mixture Alleviates Microbial Dysbiosis in Dextran Sodium Sulfate-Induced Colitis in Mice

Hydrogen Sulfide Preserves Intestinal Barrier Repair Function Through Sulfhydration of RPS20 in Experimental Colitis

Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production.

Zeolite-Containing Mixture Supplementation Ameliorated Dextran Sodium Sulfate-Induced Colitis in Mice by Suppressing the Inflammatory Bowel Disease Pathway and Improving Apoptosis in Colon Mucosa

Hydrogen-rich Water Partially Alleviate Inflammation, Oxidative Stress and Intestinal Flora Dysbiosis in DSS-induced Chronic Ulcerative Colitis Mice

Hydrogen Regulates Ulcerative Colitis by Affecting the Intestinal Redox Environment

ADT-OH improves intestinal barrier function and remodels the gut microbiota in DSS-induced colitis

Hydrogen-rich water protects against inﬂammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression.

P175 HucMSC-Exo ameliorate experimental colitis via modulating gut microbiota and metabolites

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Hydrogel-forming viscous liquid in response to ROS restores the gut mucosal barrier of colitis mice via regulating oxidative redox homeostasis

Protective Effects Of Hydrogen-Rich Saline On Ulcerative Colitis Rat Model

Exogenous H2S promotes ion channel reconstruction to regulate colonic motility in rats with dinitrobenzene sulfonic acid-induced colitis

CSE/H2S ameliorates colitis in mice via protection of enteric glial cells and inhibition of the RhoA/ROCK pathway

Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis

Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR-23a-TNFR1-NF-κB Signaling

Humic acids alleviate dextran sulfate sodium-induced colitis by positively modulating gut microbiota

Hyaluronic Acid-Melatonin Nanoparticles Improve the Dysregulated Intestinal Barrier, Microbiome and Immune Response in Mice with Dextran Sodium Sulfate-Induced Colitis.

Mitigation of Dextran-Sodium-Sulfate-Induced Colitis in Mice through Oral Administration of Microbiome-Derived Inosine and Its Underlying Mechanisms